PLx Pharma Inc.

NASDAQ:PLXP  
5.46
-0.14 (-2.50%)
Products

Plx Pharma Submits Supplemental New Drug Applications For Vazalore To U.S. FDA

Published: 11/16/2020 22:32 GMT
PLX Pharma Inc (PLXP) - Plx Pharma Inc. Submits Supplemental New Drug Applications for Vazalore™ 325 Mg and 81 Mg to U.S. Food and Drug Administration.
Plx Pharma Inc - Targeting Launch of Vazalore for Q3 2021.